Tert-butyl 2-(acetoxymethyl)-4-hydroxypiperidine-1-carboxylate → Tert-butyl 2-(acetoxymethyl)-4-oxopiperidine-1-carboxylate
Reaction equation
[C:1]([O:4][CH2:5][CH:6]1[CH2:11][CH:10]([OH:12])[CH2:9][CH2:8][N:7]1[C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])(=[O:3])[CH3:2].[Cr](Cl)([O-])(=O)=O.[NH+]1C=CC=CC=1>ClCCl>[C:1]([O:4][CH2:5][CH:6]1[CH2:11][C:10](=[O:12])[CH2:9][CH2:8][N:7]1[C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])(=[O:3])[CH3:2]Participants
4
Procedure
To a solution of the product of step H (506 mg, 1.9 mmol) in dichloromethane (15 mL) at 0° C. was added pyridinium chlorochromate (4.0 g, 19 mmol). The reaction was allowed to warm to ambient temperature and stirred for a further 2 h. The reaction mixture was filtered through celite and the filtrate was concentrated in vacuo to afford the crude product which was purified by flash column chromatography (SiO2, 19:1 to 4:1, hexanes/ethyl acetate) to afford tert-butyl 2-(acetoxymethyl)-4-oxopiperidine-1-carboxylate (220 mg, 43%) as a colorless oil: 1H NMR (CDCl3, 400 MHz) δ 4.57 (br s, 1H), 4.03-3.99 (m, 2H), 3.91-3.87 (m, 1H), 3.28-3.21 (s, 1H), 2.52-2.46 (m, 1H), 2.35-2.31 (m, 1H), 2.26-2.18 (m, 2H), 1.83 (s, 3H), 1.50 (s, 9H).
Workup
- filtrationThe reaction mixture was filtered through celite
- concentrationthe filtrate was concentrated in vacuo
- customto afford the crude product which
- customwas purified by flash column chromatography (SiO2, 19:1 to 4:1, hexanes/ethyl acetate)
Sources & evidence
- ORD record
- ord-64491a4f871646c4b715dc67ecd05b18
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09067949B2
Reaction notes
Loading…